Revised forecast
Fiscal year ending July 2027 · Six months and full yearThe bar length represents the relative magnitude of change, based on the item that changed the most in this document.
No reason for the revision of the earnings forecast was provided. Looking ahead, the company assumes a recovery in the domestic economy and cosmetics market and plans to expand the anti-aging business into skincare, develop its channel mix and media mix, build the Recovery business brand, and invest in advertising and promotion.
Loss on disposal of fixed assets: ¥62 million; business restructuring expenses: ¥206 million
| Item | Details |
|---|---|
| Net Sales | Not disclosed → Full year: 13,500; cumulative second quarter: 6,750（Full year: -2.8% year on year; cumulative second quarter: -8.1% year on year） |
| Operating profit | Not disclosed → Full year: 100; cumulative second quarter: -50（Full year: -80.0% year on year; cumulative second quarter: -） |
| Ordinary income | Not disclosed → Full year: 100; cumulative second quarter: -50（Full year: -83.4% year on year; cumulative second quarter: -） |
| Profit attributable to owners of the parent | Not disclosed → Full year: 100; cumulative second quarter: -50（Full year: -72.5% year on year; cumulative second quarter: -） |
| Net income per share | Not disclosed → Full year: 11.47; cumulative second quarter: -5.73 |
| Fiscal Period Covered | Fiscal year ending July 2027 |
| Period Covered | Six months and full year |
| Previous-period results | Fiscal year ending July 2026: net sales of ¥13,883 million, operating profit of ¥494 million, ordinary profit of ¥602 million, net income attributable to owners of the parent of ¥364 million, and net income per share of ¥41.77 |
| Reason for the revision | No reason for the revision of the earnings forecast was provided. Looking ahead, the company assumes a recovery in the domestic economy and cosmetics market and plans to expand the anti-aging business into skincare, develop its channel mix and media mix, build the Recovery business brand, and invest in advertising and promotion. |
| Details and amount of extraordinary loss | Loss on disposal of fixed assets: ¥62 million; business restructuring expenses: ¥206 million |
| Dividend forecast revision | For the fiscal year ending July 2027, the annual dividend forecast is ¥0.00 per share (interim: ¥0.00, year-end: ¥0.00). Whether the dividend forecast was revised: not disclosed. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.For the fiscal year ending July 2026, lower revenue from the anti-aging business weighed on overall net sales, while selling expenses, including advertising expenses, were below plan. The company secured operating profit through fixed-cost reductions and cost management. The main factors cited for ordinary profit and net income were foreign exchange gains and the recognition of business restructuring expenses associated with the dissolution and liquidation of a local subsidiary as the company consolidated its sales operations in China into cross-border e-commerce, respectively.